Melphalan and Tb - a phase IV clinical study of FDA data

Summary:

Tb is reported as a side effect among people who take Melphalan (melphalan), especially for people who are male, 60+ old, also take Ibrutinib, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Tb when taking Melphalan. It is created by eHealthMe based on reports of 20,050 people who have side effects when taking Melphalan from the FDA, and is updated regularly.

What is Melphalan?

Melphalan has active ingredients of melphalan. eHealthMe is studying from 20,052 Melphalan users. Check the latest studies of Melphalan.

What is Tb?

Tb (a bacterial infection by mycobacterium tuberculi) is found to be associated with 369 drugs and 1,021 conditions by eHealthMe. Check the latest studies of Tb.

On May, 27, 2026

20,050 people reported to have side effects when taking Melphalan.
Among them, 14 people (0.07%) have Tb.

Among these 14 people:

What is the gender of people who have Tb when taking Melphalan? *

female: 0.0 %
male: 100 %

What is the age of people who have Tb when taking Melphalan? *

What are other drugs people take besides Melphalan? *

Mitoxantrone: 7 people, 50.00%
Lenalidomide: 7 people, 50.00%
Ibrutinib: 7 people, 50.00%
Etoposide: 4 people, 28.57%
Cytarabine: 4 people, 28.57%
Vincristine Sulfate: 3 people, 21.43%
Prednisone: 3 people, 21.43%
Doxorubicin Hydrochloride: 3 people, 21.43%
Cyclophosphamide: 3 people, 21.43%
Cisplatin: 3 people, 21.43%

What are other side effects people have besides Tb? *

Eyelid Oedema (eyelids are swollen and contain excessive fluid): 3 people, 21.43%
Retinal Haemorrhage (bleeding from retina): 2 people, 14.29%
Rashes (redness): 2 people, 14.29%
Vascular Occlusion (sudden blockage of a blood vessel, usually with a clot): 1 person, 7.14%
Tuberculosis Of Central Nervous System (a bacterial infection of brain and spinal cord by mycobacterium tuberculosis): 1 person, 7.14%
Retinopathy (acute damage to the retina of the eye): 1 person, 7.14%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 1 person, 7.14%
Consciousness - Decreased: 1 person, 7.14%
Circulatory Collapse: 1 person, 7.14%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 8 people, 57.14%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 6 people, 42.86%
Retinoblastoma (tumour of retina): 5 people, 35.71%

* Approximation only. Some reports may have incomplete information.

Do you take Melphalan and have Tb?

- Check whether Tb is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Melphalan:

Melphalan (20,052 reports)

Tb treatments and more:

Tb (9,857 reports)

Browse all side effects of Melphalan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tb:

Tb (369 drugs)

Browse all the conditions that are associated with Tb:

Tb (1,021 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on melphalan (the active ingredients of Melphalan) and Melphalan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.